CMR Surgical Announces Over 100 Versius Systems

CMR surgery announcement more … than 100 Versius systems installed worldwide

  • CMR is deliver on his commercial strategythere of rapid global expansion with systems installed around the world and more than 5,000 clinical cases carried out

CAMBRIDGE, UNITED KINGDOM 17 November 20220seven:00 (GMT). CMR Surgical (CMR) – the global surgical robotics company – today provides an update on progress as the company announces that it has now installed over 100 Versius® Commercially surgical robotic systems. Versius was first introduced to the market in 2019 to make surgical robotics more widely accessible and affordable around the world, so that more patients can experience the benefits of minimal access surgery.

CMR has continued to develop rapidly and has now installed the next generation robotic system in Europe, Asia, Australia, Latin America and the Middle East.

Recent facilities in Europe include Institut Curie, a world-leading cancer research and control center in France, ASST Santi Paolo e Carlo in Milan and in the UK, NHS Wales has acquired four systems as part of a pioneering national surgical robotics program.

Following regulatory approval in Brazil, CMR further expanded with a number of new customers in the region with Moinhos de Vento Hospital, Hospital e Maternidade Rede D’Or São Luiz Itaim, Unimed Hospital Litoral, Baia Sul Hospital and BP Beneficencia Portuguesa de São Paulo. .

Additionally, leading institutions across India including Zen Hospital in Mumbai and GEM Hospital in Coimbatore have become the latest to start using the system as RMC increases access to robotics surgery around the world.

The global surgical robotics market continues to grow rapidly and is currently estimated at $6 billion.I. CMR is capitalizing on this growth and the momentum continues for Versius. The CMR system is the only small, portable, modular surgical robot on the market, which is an attractive proposition for customers when deploying surgical robotics programs to gain efficiency.

By Vegard NersethCEO of CMR Surgical, comments“This is an important milestone for CMR as we continue to execute on our ambitious business plans. We have seen strong and growing demand for Versius around the world over the past year as both public healthcare systems and private centers increasingly recognize the value of a small, modular and portable system. A key goal for us is always to find the right partners, and we are proud to partner with world-class hospitals and surgeons, many of whom could not previously adopt a surgical robot.

Evandro Moraes, Managing Director, Hospital Moinhos Vento’s comments“It is great to be able to offer our patients robot-assisted surgery thanks to the introduction of a new innovative system, Versius. Due to its small size and modularity, we have been able to adopt the system and bring the benefits of robotic surgery to many more patients. »

CMR is further expanding its operations worldwide to meet the demand for Versius, and work is currently underway to build a major manufacturing facility in Cambridgeshire, spanning over 7,000 square metres, which will be the center global export company. To further support CMR’s expansion strategy and help drive growth in key markets, the company plans to open additional European offices in the coming months.

This update follows the recent announcement that Versius has been used in over 5,000 clinical cases, in 128 types of procedures in specialties including gynecology, colorectal surgery, thoracic surgery, general surgery and urology.

– ENDS –

Media contacts:

If you would like to see more, please contact CMR Surgical at:

Press Office, CMR Surgical
J +44(0) 1223 755801
E [email protected]

Notes to Editors:

The Versus® Surgical robotic system

Versius® resets expectations of robotic surgery. Versius fits into virtually any operating room setup and integrates seamlessly into existing workflows, increasing the likelihood of minimal access robotic surgery (MAS). The compact, portable and modular design of Versius allows the surgeon to use only the number of arms needed for a given procedure.

Biomimicking the human arm, Versius offers surgeons the choice of optimized port placement, along with the dexterity and precision of small, full-wrist instruments. With 3D HD vision, easy-to-adopt instrument control, and a choice of ergonomic working positions, the Open Surgeon Console has the potential to reduce stress and fatigue and enables clear communication with the surgical team. By thinking laparoscopically and operating robotically with Versius, patients, surgeons and healthcare professionals can all benefit from the value that MAS robotics brings.

But it’s more than just a robot. Versius captures meaningful data with its broader digital ecosystem to support a surgeon’s continuous learning. Through the Versius Connect app, Versius Trainer and the CMR Clinical Registry, Versius unlocks a wealth of information to improve surgical care.

About CMR Surgical Limited

CMR Surgical (CMR) is a global medical device company dedicated to transforming surgery with Versius®a new generation surgical robot.

Based in Cambridge, UK, CMR is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool to make minimal access robotic surgery universally accessible and affordable. With Versius, we are on a mission to redefine the surgical robotics market with practical, innovative technology and data that can improve surgical care.

Founded in 2014, CMR Surgical is a limited company backed by international shareholders.

I Verified Market Research, 2021

Christine E. Phillips